Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

R. Kalla, A.T. Adams, D. Bergemalm, S. Vatn, N.A. Kennedy, P. Ricanek, J. Lindstrom, A. Ocklind, F. Hjelm, N.T. Ventham, G.T. Ho*, C. Petren, D. Repsilber, J. Soderholm, M. Pierik, M. D'Amato, F. Gomollon, C. Olbjorn, J. Jahnsen, M.H. VatnJ. Halfvarson, J. Satsangi*, IBD Character Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Web of Science)
Original languageEnglish
Pages (from-to)699-708
Number of pages10
JournalJournal of Crohn's & Colitis
Volume15
Issue number5
DOIs
Publication statusPublished - 1 May 2021

Keywords

  • BIOMARKERS
  • CELLS
  • CHILDREN
  • Crohn's disease
  • FECAL CALPROTECTIN
  • GENOME-WIDE ASSOCIATION
  • OSM
  • PROGNOSIS
  • RISK
  • genetics
  • inflammatory bowel diseases [IBD]
  • outcomes
  • prognosis
  • protein quantitative trait loci
  • proteins
  • proximity extension assay
  • ulcerative colitis
  • THERAPY

Cite this